购物车
- 全部删除
- 您的购物车当前为空
EGFRT790M/L858R-IN-7(Compound 72)作为一种新型嘧啶类化合物,能够有效抑制带有T790M和L818R突变的EGFRL(在0.05 μM浓度下,抑制率达到93%)。通过特异性结合至EGFR的激酶域,此化合物进一步阻断了其磷酸化活性。
EGFRT790M/L858R-IN-7(Compound 72)作为一种新型嘧啶类化合物,能够有效抑制带有T790M和L818R突变的EGFRL(在0.05 μM浓度下,抑制率达到93%)。通过特异性结合至EGFR的激酶域,此化合物进一步阻断了其磷酸化活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | EGFR T790M/L858R-IN-7 (Compound 72), a novel pyrimidine compound, exhibits high efficacy in inhibiting the EGFR T790M and L858R mutations, with a 93% inhibition rate at 0.05 μM. It achieves its inhibitory action by specifically binding to the kinase domain of EGFR, which prevents phosphorylation activity [1]. |
分子量 | 515.56 |
分子式 | C27H29N7O4 |
CAS No. | 3032760-90-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容